| 证券代码 | IVTY.O |
| 证券名称 | Invuity Inc |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | 主板 |
| 发行方式 | 公开发售 |
| 首发上市日 | 2015-06-15 |
| 首发价格(元) | 12 USD |
| 首发数量(股) | 4000000 |
| 首发募资额(元) | 48,000,000.00 USD |
| 首发主承销商 | Leerink Partners LLC,Piper Jaffray & Co.,Stifel Nicolaus & Compa |
| 货币单位 | USD |
| 公司名称 | Invuity, Inc. |
| 注册地址 | 美国特拉华州 |
| 办公地址 | 444 De Haro Street, San Francisco, California, USA |
| 成立日期 | 2004-11-29 |
| 董事会主席 | - |
| 公司属地 | United States 美国 |
| 公司网址 | www.invuity.com |
| 电话 | +1 (415) 665-2100 |
| 传真 | - |
| 公司简介 | Invuity, Inc. is a leading medical technology company focused on developing and marketing advanced surgical devices to improve the ability of physicians to perform minimal access surgery through smaller and hidden incisions. The Company’s patented Intelligent Photonics technology delivers enhanced visualization, which facilitates surgical precision, efficiency and safety. Clinical applications include women’s health, encompassing breast cancer and breast reconstruction surgery, gynecology and thyroid surgery. Additional applications include procedures for electrophysiology, spine, orthopedic, cardiothoracic and general surgery. Invuity is headquartered in San Francisco, CA. |